We’re keeping our finger on the pulse and bring you a summary of the latest business updates from the global poultry industry ...

Boehringer Ingelheim’s weight-loss drug candidate ... dysfunction-associated steatotic liver disease (MASLD), which in turn has been rebranded from non-alcoholic fatty liver disease (NAFLD).

Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisor, ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

Boehringer Ingelheim has moved one of its top pipeline ... The first patient has already been enrolled into its FIBRONEER phase 3 programme for BI 1015550, which already has a breakthrough ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

3,4 Despite the requirement of continued therapy to achieve a benefit with golimumab and baricitinib, these interventions modified the course of type 1 diabetes, resulting in reduced insulin need, ...

Can’t end turn bug explained and troubleshooting fixes for Baldur’s Gate 3 Want to learn how to exit turn-based mode in Baldur’s Gate 3? With both PC and PS5 players hunting for Faerun’s ...

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis ...

Donald Trump is on course for another term as US president after an exclusive poll revealed he holds narrow leads in the three northern swing states. The 45th president, who has sold 71,000 black ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...